Palantir Ends 2026 Below $150. The Clock Has Only Two Dates Left.

Palantir closes 2026 below $150. The stock, $175 and change as I write this on August 20, has four months and one earnings report to fall roughly 15 percent and prove that its year was not one round-trip but two. The Street is not positioned for that outcome. The average analyst target sits just under $210, essentially at the $207.52 all-time high the stock set late last year. The market has already written the ending it expects: another quarter, another hike, a new record. I am buying the other ending, and I want it on the record with a scoring rule, because a forecast with no way to lose is a press release with extra words.

That forecast misses the variable that now controls the clock. Palantir's business is not the problem. The problem is what the price already charges for that business, and the only two dates left on the calendar that can move the multiple: the third-quarter report in early November and the final close on December 31.

The contract

• Subject and direction: Palantir Technologies (PLTR), down.
• Number: closes below $150 on December 31, 2026.
• Measurement: NASDAQ closing price on that date.
• Conviction: roughly four-in-ten for ending below $150, against perhaps one-in-ten implied by the market's own pricing.
• Scoring: below $150 is a hit; $150 to $176 is a partial (direction right, magnitude short); above $176 is a miss. Mechanism scored separately: the move must come from a compression in the price-to-sales multiple, not from a broken business.
• Kill condition: if Palantir logs any daily close above $207.52 before year-end, the reset is off the board and the call is dead.

Here is why the consensus line is a trap. Palantir delivered revenue of $1.94 billion last quarter, up 93 percent, with U.S. commercial revenue up 149 percent to $764 million. Adjusted earnings of 41 cents a share beat the 35 cents Wall Street expected. The company raised its full-year 2026 revenue guidance to 82 percent growth, its third adjustment upward this year. This was the eighth consecutive quarter of beating estimates. The bulls' argument is not mythical; it is documented.

Now weigh the ledger against that price. Palantir trades at roughly 68 times trailing revenue, about 52 times the $8.15 billion it now guides for this year, and 140 times trailing earnings. AInvest's aggregate scoring system labels the stock a Buy and gives it a liquidity score of 7.86, yet scores its fundamentals at 0.34 on the same scale. When the fundamentals grade and the analyst grade disagree by that much, one of them is describing something other than the same company. The analyst grade is describing the narrative. The fundamentals grade is describing the multiple.

The market's pricing makes the disagreement legible. The 2026 trajectory is already one full round-trip: a record near $208, a 49 percent slide to a low around $106 this summer, then a 40 percent melt-up in twenty days back to where the year began. A name that halves from its high inside nine months does not need a disaster to give back the latest spike; it needs one quarter that merely matches the raised bar.

The causal clock has four hands, and only the first is run by the company.

One: the guidance itself is a deceleration notice. The full-year target calls for U.S. commercial growth of 134 percent, but the second quarter already printed 149 percent and the first printed 133 percent. For the year to land at 134 percent, the back half has to grow slower than the second quarter did. That is not a bearish reading; it is the company's own arithmetic. The third-quarter guide of about $2.16 billion in revenue keeps the machine growing, but at a pace the 52-times-sales price has already absorbed. Reported 93 percent revenue growth is no longer enough to move a stock whose premium assumes the number holds forever.

Two: the people who know the business best are sellers into strength. Insiders have executed 59 transactions in the past 90 days, every one of them a sale, totaling roughly $313 million, and that follows a substantial disposal by co-founder Peter Thiel earlier in the year. Insider selling is the least ambiguous signal in this entire setup, not because insiders know the future, but because they own the shares already and their cost basis is near zero. Sellers of that kind are not betting against the company; they are indifferent to the price giving it back.

Three: the money that just ran prices in is trying to leave. On the very day Palantir rose two percent this week, the flow data showed a net outflow in every size class — block, large, medium, and retail. Money distributing into a rising tape is the signature of a chase that has run out of fresh buyers. One day is one day. But it rhymes with the 40-day tape, where every marginal dollar is now a momentum dollar with a shorter leash.

Four: the calendar leaves one report, and it is the worst-placed report of the year. The only earnings catalyst inside the window is the early-November print. By then, estimates and targets have been raised three times this year; the marginal buyer needs a fourth kind of surprise to justify a higher multiple. The most likely gift from that report is a fully expected beat paired with a first real look at 2027 growth, which will decelerate for the mechanical reason that 149 percent comparisons do. The first deceleration number is the moment the premium stops expanding.

Now name the forced sellers, because a forecast without them is a thought experiment. The momentum funds and options buyers who grabbed the August surge hold the marginal position. Their thesis is simple: beats keep coming, keep holding. That thesis only fails at the moment a good quarter can no longer expand the multiple — which is exactly the moment the guided deceleration creates. When the premium stalls, the exit is crowded onto one side, and a 52-times-sales stock has a long way to fall before value investors show up to stop it. Burry stood on the other side of this trade in February and called the stock worth as little as $46; the market laughed at the level while confirming the direction, cutting the stock nearly in half before the recovery.

The strongest objection deserves a straight answer: Palantir's revenue growth has now accelerated for twelve consecutive quarters, bookings grew 153 percent, U.S. commercial revenue rose 28 percent sequentially in the second quarter, and management insists demand momentum runs at least eighteen more months. All true, and all already inside the price. A stock at 52 times this year's sales does not need a bad quarter to fall; it needs an uncharming one. The records of the last twelve quarters bought the present premium, not the future one, and future premiums are priced off the 2027 growth number nobody has heard yet.

The break condition is observable before the verdict. If the November report delivers another guidance raise alongside U.S. commercial growth still above 140 percent with more than 25 percent sequential growth, the reset slows and I downgrade to a partial before Christmas. If the tape clears resistance at $180.04 and runs at the record, the call is gone and I will say so. Expect the confirmation signal first: a daily close through $168.20, the support the market has been defending, on real volume, turns the stall into a slide.

The scoreboard has no sympathy built in. Below $150, I count the receipt a win, with extra credit if the move comes from multiple compression rather than an earnings stumble, because that sequence is the mechanism I am actually forecasting. Above $176, I count it a miss and the autopsy begins with the counterargument above, because it will have been the twelve-quarter streak that won, not my reading of the multiple. The partial zone — $150 to $176 — means I called the direction and bungled the magnitude; direction keeps me in the trade, magnitude keeps me humble, and only the untouched receipt decides which.

Palantir is a great company. That is precisely why the fourth quarter is the dangerous one. A great company with a fully paid-for year does not need to fail to disappoint; it needs to merely perform. The first alarm date is late October through early November, when the next report lands and the market finally hears a number for 2027. If U.S. commercial sequential growth skips a beat, the $150 close writes itself before Santa rallies. If it does not, I have handed you a loss ledger with my signature on it, and you are welcome to audit it in January.